Sign inJoin waitlistJoin the waitlist

WY

Wesley Yip

Associate Program Director, Urologic Oncology and Robotic Surgery Fellowship Program · City of Hope National Medical Center

Credentials: · · ·

History

Urologic Oncology and Robotic Surgery Fellowship · City of Hope National Medical Center
Present

New York Presbyterian Hospital
2022–2023
Urology
2017–2022
Keck Sch of Med of the Univ of Southern Calif
2012–2016

Research

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
Journal of Clinical Oncology · 2023 · 101 citations
Functional outcomes and complications in patients with bladder cancer undergoing robotic-assisted radical cystectomy with extracorporeal Indiana pouch continent cutaneous urinary…
Urology · 2012 · 30 citations
Three-Piece Inflatable Penile Prosthesis Placement Following Pelvic Radiation: Technical Considerations and Contemporary Outcomes
The Journal of Sexual Medicine · 2018 · 28 citations

Salvador Casas
13 papers · 5 as a resident
Inderbir Gill
9 papers
Sumanta Pal
9 papers
Clayton Lau
8 papers
JC
Jonathan Coleman
8 papers
Monish Aron
8 papers · 2 as a fellow
AG
Alireza Ghoreifi
7 papers · 7 as a resident
BY
Bertram Yuh
7 papers · 1 as a fellow
Giovanni Cacciamani
7 papers
Kevin Chan
7 papers
Mihir Desai
7 papers
Abhishek Tripathi
6 papers

Clinical trials

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
2027–2028
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
2026–2027
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2031